NXTC
Price
$4.99
Change
-$0.14 (-2.73%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
11.99M
13 days until earnings call
ORMP
Price
$2.10
Change
-$0.02 (-0.94%)
Updated
Jul 18, 04:39 PM (EDT)
Capitalization
86.6M
26 days until earnings call
Interact to see
Advertisement

NXTC vs ORMP

Header iconNXTC vs ORMP Comparison
Open Charts NXTC vs ORMPBanner chart's image
NextCure
Price$4.99
Change-$0.14 (-2.73%)
VolumeN/A
Capitalization11.99M
Oramed Pharmaceuticals
Price$2.10
Change-$0.02 (-0.94%)
Volume$200
Capitalization86.6M
NXTC vs ORMP Comparison Chart in %
Loading...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NXTC vs. ORMP commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NXTC is a Hold and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (NXTC: $5.13 vs. ORMP: $2.12)
Brand notoriety: NXTC and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NXTC: 155% vs. ORMP: 53%
Market capitalization -- NXTC: $11.99M vs. ORMP: $86.6M
NXTC [@Biotechnology] is valued at $11.99M. ORMP’s [@Biotechnology] market capitalization is $86.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NXTC’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • NXTC’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, both NXTC and ORMP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NXTC’s TA Score shows that 3 TA indicator(s) are bullish while ORMP’s TA Score has 2 bullish TA indicator(s).

  • NXTC’s TA Score: 3 bullish, 5 bearish.
  • ORMP’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both NXTC and ORMP are a bad buy in the short-term.

Price Growth

NXTC (@Biotechnology) experienced а -8.69% price change this week, while ORMP (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

NXTC is expected to report earnings on Oct 30, 2025.

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($86.6M) has a higher market cap than NXTC($12M). ORMP YTD gains are higher at: -12.397 vs. NXTC (-44.553). ORMP has higher annual earnings (EBITDA): -21.53M vs. NXTC (-50.34M). ORMP has more cash in the bank: 131M vs. NXTC (15.4M). ORMP has less debt than NXTC: ORMP (301K) vs NXTC (4.91M). ORMP has higher revenues than NXTC: ORMP (2M) vs NXTC (0).
NXTCORMPNXTC / ORMP
Capitalization12M86.6M14%
EBITDA-50.34M-21.53M234%
Gain YTD-44.553-12.397359%
P/E RatioN/A20.91-
Revenue02M-
Total Cash15.4M131M12%
Total Debt4.91M301K1,632%
FUNDAMENTALS RATINGS
NXTC vs ORMP: Fundamental Ratings
NXTC
ORMP
OUTLOOK RATING
1..100
357
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
6577
P/E GROWTH RATING
1..100
10045
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NXTC's Valuation (13) in the Biotechnology industry is somewhat better than the same rating for ORMP (56) in the Pharmaceuticals Other industry. This means that NXTC’s stock grew somewhat faster than ORMP’s over the last 12 months.

NXTC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that NXTC’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as NXTC (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to NXTC’s over the last 12 months.

NXTC's Price Growth Rating (65) in the Biotechnology industry is in the same range as ORMP (77) in the Pharmaceuticals Other industry. This means that NXTC’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for NXTC (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than NXTC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NXTCORMP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 17 days ago
85%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FBPI9.260.01
+0.11%
First Bancorp of Indiana, Inc.
AYALY9.96N/A
N/A
Ayala Corp.
DACHF8.43N/A
N/A
Daicel Chemical Industries Ltd.
MAYX5.55N/A
N/A
Mayex USA, Inc.
CSCMY0.43-0.07
-13.60%
COSCO Shipping International (Singapore) Co., Ltd.